Join
Live feed
·
INSIDERFilingvia Quantisnow
Cara Therapeutics Inc. logo

SEC'Y; CHIEF COMPLIANCE & G.C. Terrillion Scott sold $776 worth of shares (163 units at $4.76), decreasing direct ownership by 2% to 7,190 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CARA· Cara Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CARA (Cara Therapeutics Inc.) and more on Quantisnow.